©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2013; 19(42): 7327-7340
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7327
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7327
Table 2 Drug induced hepatobiliary manifestations in inflammatory bowel disease
| Manifestation | Drug |
| Drug induced hepatitis | Azathioprine |
| 6-mercaptopurine | |
| Methotrexate | |
| Cyclosporine | |
| Infliximab | |
| Reactivation of hepatitis B | Anti-TNF therapy |
| Corticosteroids | |
| Drug induced pancreatitis | Azathioprine |
| 6-mercaptopurine | |
| Methotrexate | |
| Hepatosplenic T-cell lymphoma | Combination of anti-TNF and immunosuppressive therapy |
- Citation: Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M. Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver. World J Gastroenterol 2013; 19(42): 7327-7340
- URL: https://www.wjgnet.com/1007-9327/full/v19/i42/7327.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i42.7327